Clofazimine: A useful antibiotic for drug-resistant tuberculosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clofazimine: A useful antibiotic for drug-resistant tuberculosis

Published:2018-09 Issue: Volume:105 Page:1353-1359
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Mirnejad Reza,Asadi Arezoo,Khoshnood Saeed,Mirzaei Habibollah,Heidary Mohsen,Fattorini Lanfranco,Ghodousi Arash,Darban-Sarokhalil Davood

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference69 articles.

1. Global Tuberculosis Report 2017;World Health Organization,2017

2. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update;Falzon;Eur. Respir. J.,2017

3. WHO treatment guidelines for drug-resistant tuberculosis, 2016 update: applicability in South Korea;Jeon;Tuberc. Respir. Dis.,2017

4. Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis;Dey;J. Antimicrob. Chemother.,2012

5. WHO Treatment Guidelines for Drug-Resistant Tuberculosis 2016 Update;World Health Organization,2016

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms of resistance and treatment efficacy of clofazimine and bedaquiline against Mycobacterium tuberculosis;Frontiers in Medicine;2024-01-10

2. QSPR analysis of distance-based structural indices for drug compounds in tuberculosis treatment;Heliyon;2024-01

3. Exploiting Differences in Heme Biosynthesis between Bacterial Species to Screen for Novel Antimicrobials;Biomolecules;2023-10-06

4. Non-tuberculous mycobacterial disease: progress and advances in the development of novel candidate and repurposed drugs;Frontiers in Cellular and Infection Microbiology;2023-10-02

5. Multitargeting: An Alternative Approach to Tackle Multidrug Resistance in Tuberculosis;Current Drug Targets;2023-08-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3